Can weight loss drugs help with dementia risk? Here's what studies suggest.
Popular weight loss drugs may do more than curb appetite — they may also help reduce the risk of dementia, according to new research.
Weight Loss
Weight loss drugs could help curb dementia
Two new studies in JAMA Neurology show some diabetes and popular weight loss drugs could help to protect against dementia. CBS News medical contributor Dr. Celine Gounder joins "CBS Mornings" to explain what researchers found.
Weight loss drugs might reduce dementia risk
Two new studies suggest the class of weight loss and diabetes drugs that includes Ozempic and Wegovy have the added benefit of protecting against the development of dementia. CBS News medical contributor Dr. Céline Gounder has more.
FDA declares end to Wegovy and Ozempic shortage
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.
FDA says Ozempic, Wegovy are not limited anymore
The U.S. Food and Drug Administration said Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply. CBS News New York reporter Ali Bauman reports on whether the supply change could lead to consumers paying more.
11/15: CBS News Mornings
Israel military launches "precise and targeted operation against Hamas in a specified area" of Al-Shifa hospital in Gaza; doctors see soaring demand for weight-loss drugs.
New recommendations to measure obesity go beyond controversial BMI
Body Mass Index, or BMI, has long been criticized as an unreliable method for measuring obesity — and now a group of experts is sharing new recommendations for how to use it.
How much exercise impacts weight loss
The Journal of the American Medical Association published a review of more than 100 clinical trials that found at least 2.5 hours of moderate to higher intensity aerobic exercise per week "may help lead to a meaningful decrease" in weight, waist size and body fat. CBS News medical contributor Dr. Celine Gounder explains.
Why some children are turning to GLP-1 drugs
A growing number of young people are receiving prescriptions for GLP-1 weight loss medications like Ozempic and Wegovy. Janet Shamlian examines why.
Does microdosing weight loss drugs work?
The demand for weight loss drugs, like Ozempic and Wegovy, has skyrocketed in the past few years despite the high cost and unpleasant side effects for some people. The New York Times reports some patients are finding a way around both of these concerns by experimenting with microdosing the drugs. Dr. Jeremy Faust, emergency physician at Brigham and Women's Hospital in Boston, joins CBS News to assess the safety and risks of the practice.
New White House rule expands GLP-1 access
A New White House proposal would make Medicare and Medicaid cover GLP-1 weight loss drugs for people who are obese. The move would expand affordable access to the drugs to some 7.4 million people. Dr. Jon LaPook has more.
Doctor on Biden's GLP-1 drug coverage plan
The Biden administration is proposing a new rule that would make popular weight loss drugs like Ozempic covered by Medicare and Medicaid. CBS News medical contributor Dr. Celine Gounder discusses whether the current or next administration can make this happen.
Biden's weight loss drug coverage plan
President Biden's proposal for Medicaid and Medicare coverage for weight loss drugs such as Ozempic and Wegovy could draw opposition from the drug industry and President-elect Donald Trump's administration. Julie Rovner, the chief Washington correspondent for Kaiser Health News, joins CBS News with more.
Why Thanksgiving may feel different for Americans on weight loss drugs
This may be the first Thanksgiving for millions of Americans who are on GLP-1 agonists like Ozempic, Zepbound or Wegovy.
As many as 1 in 5 people won't lose weight with GLP-1 drugs, experts say
About 20% of patients — as many as 1 in 5 — may not respond well to medications like Mounjaro and Wegovy, according to several obesity experts.
Counterfeit weight loss drugs could harm health
The demand for weight loss drugs like Ozempic and Wegovy has led to a flood of fake drugs hitting the market. However, these counterfeit medicines can be harmful to people's health. Tom Hanson has more.
Counterfeit weight loss drugs feed demand for cheaper options
Record demand for Ozempic, Wegovy and other weight loss drugs is fueling a surge of dangerous knockoffs.
Counterfeit weight loss drugs flood internet
A surge in counterfeit versions of popular weight loss drugs is raising health concerns. U.S. Customs is intercepting fake medications with potentially harmful effects. Tom Hanson reports on the risks and how consumers can protect themselves.
How a love story launched the company behind Ozempic, Wegovy
Novo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders, a married couple, were looking for a way to tackle diabetes, which the wife suffered from.
Weight loss drugs could help with alcohol, opioid addiction, study says
Drugs like Mounjaro and Ozempic, which many use for weight loss, may also help patients suffering from addiction, according to a new study.
Should you try a trending "cortisol cocktail" for stress and weight loss?
TikTok's latest wellness concoction is dubbed the "adrenal" or "cortisol cocktail," which users claim can reduce stress and even help with weight loss. We asked experts to weigh in.
Obesity rate in U.S. adults no longer growing, new CDC data suggests
The latest CDC survey found 4 in 10 adults in the U.S. were obese. A map shows the states with the highest and lowest rates.
Inside the thriving market for alternatives to brand-name weight loss drugs
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the meantime, a market for cheaper, compounded drugs thrives.
Weight loss drugs allegedly landed this woman in the hospital. She's suing.
Do weight loss drug labels warn enough about potential side effects? A patient who needed emergency surgery is suing prescription drugmaker Novo Nordisk.
Prices slashed on weight-loss drug Zepbound
Eli Lilly is slashing prices for certain doses of its weight loss drug Zepbound, selling single-dose vials at much cheaper prices for people who pay out of pocket. Dr. Timothy Mackey, professor in the Global Health Program at the University of California, San Diego, joined CBS News to discuss the price cuts.
ICE officer relieved of duties after videos show him shoving woman to ground
An ICE officer who was captured on video pushing a woman to the ground outside an immigration court in New York City has been relieved of his duties.
Sinclair says it will bring back "Jimmy Kimmel Live!" on its stations
Sinclair said it will return "Jimmy Kimmel Live!" to the air on its stations Friday after it had preempted the show.
Former FBI Director James Comey indicted on 2 counts
President Trump's Justice Department has brought criminal charges against James Comey, indicting him on two counts, though a federal grand jury rejected one count.
Breaking
NYC mass shooting gunman had CTE, medical examiner finds
The gunman in the deadly Midtown Manhattan shooting, Shane Tamura, wrote about the brain disease CTE in a note obtained by investigators.
Israel's Netanyahu addresses U.N. as some delegates walk out
As Israel's Prime Minister Benjamin Netanyahu began speaking at the U.N. General Assembly in New York, dozens of people walked out of the room in protest.
Assata Shakur dies in Cuba after decades on the run
Assata Shakur, also known as Joanne Chesimard, was convicted of murdering a state trooper in 1973 and escaped prison in 1979.
Coast Guard releases image of alleged drug boat on fire after seizures
The Coast Guard says it seized nearly 30,000 pounds of cocaine from alleged drug boats in recent weeks.
Survivor of flesh-eating bacteria says she has "more appreciation" for life
As flesh-eating bacteria cases rise across the U.S., an Alabama woman is sharing her story of surviving Vibrio and the year-long recovery ahead.
House Judiciary Democrats launch probe of Virginia U.S. attorney's ouster
Former U.S. Attorney Erik Siebert resigned a week ago. On Thursday, former FBI Director James Comey was indicted.